1. Home
  2. SAMG vs CGTX Comparison

SAMG vs CGTX Comparison

Compare SAMG & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silvercrest Asset Management Group Inc.

SAMG

Silvercrest Asset Management Group Inc.

HOLD

Current Price

$13.30

Market Cap

101.0M

Sector

Finance

ML Signal

HOLD

Logo Cognition Therapeutics Inc.

CGTX

Cognition Therapeutics Inc.

HOLD

Current Price

$0.96

Market Cap

94.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAMG
CGTX
Founded
2002
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.0M
94.5M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
SAMG
CGTX
Price
$13.30
$0.96
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$3.33
AVG Volume (30 Days)
42.0K
1.5M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
6.43%
N/A
EPS Growth
N/A
62.79
EPS
0.56
N/A
Revenue
$91,358,000.00
N/A
Revenue This Year
$8.99
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$23.32
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.79
$0.22
52 Week High
$16.97
$3.83

Technical Indicators

Market Signals
Indicator
SAMG
CGTX
Relative Strength Index (RSI) 43.57 50.18
Support Level $13.27 $0.55
Resistance Level $16.83 $1.19
Average True Range (ATR) 0.57 0.13
MACD 0.04 0.01
Stochastic Oscillator 31.06 63.89

Price Performance

Historical Comparison
SAMG
CGTX

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income, and cash, as well as non-traditional investment strategies including hedge funds, private equity funds, real estate, and commodities. The firm offers a full suite of complementary and customized family office services for families seeking comprehensive oversight of their financial affairs. The company derives revenues from Managed accounts, Silvercrest funds, Tax and family office services, and Fund administration. The firm generates the majority of its revenue from Managed Accounts.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: